P499 Accessing ultrasonographic transmural healing in patients with Crohn’s disease after induction therapy with infliximab: should we aim for higher infliximab trough levels?B Morão, Carolina Palmela, Guilherme Macedo et al.|Journal of Crohn s and Colitis|2022Cited by 1
P505 Early therapeutic drug monitoring after induction therapy with infliximab: correlation with intestinal ultrasoundCatarina Nascimento, Carolina Palmela, B Morão et al.|Journal of Crohn s and Colitis|2021Cited by 0
P152 Bowel ultrasound as an early monitoring tool to assess disease activity in Crohn’s disease patients after induction therapy with infliximabB Morão, Carolina Palmela, Catarina Nascimento et al.|Journal of Crohn s and Colitis|2021Cited by 0
P375 Faecal calprotectin variation after induction therapy with infliximab to predict clinical, endoscopic and ultrasonographic remission in Crohn’s disease patientsJoana Revés, Carolina Palmela, B Morão et al.|Journal of Crohn s and Colitis|2022Cited by 0
P333 Early intestinal ultrasound remission is associated with endoscopic healing after one year of infliximab therapy in Crohn’s disease: a multicentre prospective studyJoana Revés, C Palmela, B Morão et al.|Journal of Crohn s and Colitis|2023Cited by 0